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Abstract The rapid decline of injury-induced neuronal
circuit remodelling after birth is paralleled by the accu-
mulation of chondroitin sulphate proteoglycans (CSPGs)
in the extracellular matrix, culminating with the
appearance of perineuronal nets (PNNs) around parval-
bumin-expressing GABAergic interneurons. We used a
spinal cord injury (SCI) model to study the interplay
between integrity of PNN CSPGs in the sensorimotor
cortex, anatomical remodelling of the corticospinal tract
(CST) and motor recovery in adult mice. We showed
that thoracic SCI resulted in an atrophy of GABAergic
interneurons in the axotomized hindlimb cortex, as well
as in a more widespread downregulation of parvalbumin
expression. In parallel, spontaneous changes in the
integrity of CSPG glycosaminoglycan (GAG) chains
associated with PNNs occurred at the boundary between
motor forelimb and sensorimotor hindlimb cortex, a
region previously showed to undergo reorganization after
thoracic SCI. Surprisingly, full digestion of CSPG GAG
chains by intracortical chondroitinase ABC injection
resulted in an aggravation of motor deficits and reduced
sprouting of the axotomized CST above the lesion.
Altogether, our data show that changes in the expression
pattern of GABAergic markers and PNNs occur in
regions of the sensorimotor cortex undergoing
spontaneous reorganization after SCI, but suggest that
these changes have to be tightly controlled to be of
functional benefit.
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Introduction
An incomplete spinal cord injury (SCI) is followed by
spontaneous anatomical and functional reorganization of
motor circuits at multiple levels of the neuraxis (Oudega
and Perez 2012; Raineteau and Schwab 2001). After a
thoracic lesion, axotomized hindlimb corticospinal neu-
rons located at the boundary between motor forelimb
(mFL) and sensorimotor hindlimb (smHL) cortical areas
are functionally incorporated into the sensorimotor cir-
cuits of the unaffected forelimb (Fouad et al. 2001;
Ghosh et al. 2009, 2010). In parallel, sprouting of axo-
tomized corticospinal fibres occurs in the spinal cord,
both rostrally and caudally to the site of injury (Fouad
et al. 2001; Weidner et al. 2001; Ghosh et al. 2009;
Courtine et al. 2008), leading to the formation of new
functional circuits and the partial re-establishment of
supraspinal motor control (Bareyre et al. 2004; Fouad
et al. 2001; Ghosh et al. 2010). These compensatory
responses are however limited and not sufficient to
support complete functional recovery. Chondroitin sul-
phate proteoglycans (CSPGs), perineuronal nets (PNNs)
and parvalbumin-expressing (PV?) interneurons are
some of the main factors which limit experience-depen-
dent remodelling of adult neuronal circuits. CSPGs are
the main components of the mature extracellular matrix
(ECM) where they are diffusely expressed or aggregated
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as PNNs mainly around PV? interneurons. In the cortex,
PNN appearance regulates the maturation of PV inhibi-
tory circuits and correlates with the gradual closure of
the critical period for plasticity (Pizzorusso et al. 2002;
Sale et al. 2007; Makara et al. 2007; Beurdeley et al.
2012; Dityatev et al. 2007). Chondroitinase ABC
(ChABC)-mediated digestion of CSPGs and PNNs in
animal model of SCI promotes axonal regeneration at the
site of injury (Bradbury et al. 2002; Carter et al. 2008;
Chau et al. 2004; Moon et al. 2001; Cafferty et al. 2007)
and enhances functional sprouting of both intact and
injured pathways rostral and caudal to the lesion site
(Barritt et al. 2006; Cafferty et al. 2008; Massey et al.
2006; Starkey et al. 2012; Tom et al. 2009; Bradbury
et al. 2002; Caggiano et al. 2005; Fouad et al. 2005;
Tester and Howland 2008). In the adult visual cortex,
ChABC-mediated PNN digestion restores ocular domi-
nance plasticity (Pizzorusso et al. 2002). In the same
system, pharmacological reduction of GABAergic trans-
mission leads to a decrease in the expression of cortical
PNNs and reactivation of ocular dominance plasticity
(Harauzov et al. 2010). In animal models of stroke,
spontaneous downregulation of PNN expression occurs in
cortical area (i.e. peri-infarct and remote areas) known to
undergo compensatory remodelling of neuronal networks
(Bidmon et al. 1998; Hobohm et al. 2005). Thus,
CSPGs, PNNs and PV? cells act in concert to restrict
anatomical and functional plasticity of the injured adult
CNS.
In this study, we investigated the consequences of a
thoracic SCI on the expression of GABAergic markers and
PNN CSPGs across the mouse sensory and motor cortical
areas which are known to undergo sustained reorganization
after SCI (Ghosh et al. 2009, 2010). We showed that SCI
induced a localized and layer-specific modulation of the
cortical inhibitory system and led to changes in the integrity
of PNN CSPGs at the boundary between the motor forelimb
(mFL) and the sensorimotor hindlimb (smHL) cortical
areas. Intracortical injection of ChABC to further digest
CSPG GAG chains did however not promote functional
recovery. Contrariwise, it prevented spontaneous sprouting
of the axotomized CST neurons in the cervical spinal cord
and resulted in a transient, limb-specific aggravation of
motor deficits, suggesting that these cortical changes must
be tightly controlled to be of functional benefit.
Methods
C57BL/6 and GAD67-GFP female mice (mean age
2.5 months, n = 54) were used in this study. All surgical
procedures and experimental manipulations were performed
in agreement with Canton of Zurich Veterinary Office
guidelines.
Experimental design
Mice were divided into seven experimental groups as
indicated in Table 1. Heterozygous knock-in mice
expressing an enhanced green fluorescent protein (EGFP)
under the glutamic decarboxylase GAD67 genomic regu-
latory sequences (i.e. GAD67?/EGFP mice) were used in
groups 1 and 2 to study the effects of thoracic SCI on the
expression of cortical GABAergic markers and PNNs. In
this knock-in mouse line, 95 % of GABAergic cells
express GFP in a spatially and temporally regulated man-
ner (Tamamaki et al. 2003). These animals were eutha-
nized 2 weeks after SCI. Wild-type C57BL/6 mice were
used in groups 3–7. Mice of group 3 were euthanized at 2,
7 and 14 days after cortical injection of ChABC to estimate
the diffusion of the enzyme. Mice of groups 4–7 were used
to address the extent of locomotor recovery after SCI and
the role of cortical CSPG GAG chains digestion on the
spontaneous cervical sprouting of axotomized hindlimb
corticospinal neurons. Mice received a cortical injection of
ChABC (groups 5 and 7) or of the control enzyme peni-
cillinase (Pase; groups 4 and 6). Groups 6 and 7 underwent
in addition a dorsal thoracic hemisection. All mice were
tested for locomotor recovery ability and received an
anterograde tracer injection at 28 days post-injury (dpi) to
trace their CST. All mice from groups 4–7 were euthanized
6 weeks after injury.
Surgical procedures
Mice were anaesthetized using a combination of Hypnorm
(fentanyl-citrate 0.7 mg/kg, fluanisone 22.5 mg/kg, Janssen
Pharmaceutics) and Dormicum (midazolam 22.5 mg/kg,
Roche Pharmaceuticals) administered via intraperitoneal
injection.
Groups 4–7 underwent cortical injection of Pase or
ChABC prior to SCI (details in Table 1). Mice were
secured in a stereotaxic frame. A midline incision of the
skin was performed and the location of the sensorimotor
hindlimb cortex (smHL) was determined relative to
Bregma. 1 ll of enzymatic solution was injected using a
33-gauge Hamilton syringe (1.25 mediolateral; -0.96 ro-
strocaudal; 0.6 dorsoventral). After injection, the needle
remained in position for 2 min before removal to prevent
spillage of the enzymatic solution.
In groups 2, 6 and 7, a dorsal bilateral laminectomy was
performed at thoracic level 8 (T8) to expose the dura, and a
bilateral dorsal spinal cord hemisection was performed
using sharp iridectomy scissors. In 3 mice of group 2, a
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retrograde tracer was applied to the injury site as described
below.
Following surgery, all animals were kept on a heating
plate (36 C) until fully awake. An analgesic (5 mg/kg
body weight per subcutaneous injection of Rimadyl;
Pfizer) and an antibiotic (5 mg/kg body weight intra-
peritoneal injection of Baytril; Bayer) were administered
once per day for 3 days. Bladders were checked and
emptied three times per day until their function had
completely recovered.
Tracing of the CST
Retrograde tracing (mapping of the axotomized smHL
area): at the time of axonal injury, 1 ll of the retrograde
tracer Diamidine Yellow (DY, 1 %; suspension in
phosphate buffer (PB) 0.1 M and 2 % dimethyl sulph-
oxide, EMS-Polyloy, Gross-Umstadt, Germany) was
applied at the lesion site with a 33-gauge Hamilton
syringe mounted on the stereotaxic frame in 3 mice of
group 2. The suspension was left on the transected sur-
face for 15 min.
Anterograde tracing: 4 weeks after surgery, the CST of
mice of groups 4–7 was anterogradely traced from the
smHL ipsilateral to the treated cortex. Mice were anaes-
thetized as indicated above and secured in a stereotaxic
frame. A midline incision of the skin was performed and
the location of the smHL was determined by measuring
positions on the skull relative to Bregma. 1-ll of biotin-
ylated dextran amine (BDA) solution (10,000 MW, 10 %
in PB 0.1 M, Molecular Probes) was injected in the smHL
cortical area using a 33-gauge Hamilton syringe.
Enzymatic treatment
To digest cortical CSPG GAG chains, protease-free
chondroitinase ABC (ChABC) from Proteus vulgaris
(Seikagaku) was reconstituted in sterile PB 0.1 M
(0.1 U/ll, pH 7.4) and 1 ll was injected in the hindlimb
area as indicated above. ChABC digests the GAG chains
from the protein core of CSPGs that are diffusely
expressed in the ECM or aggregated as PNNs. Pase
(matched for protein content in PB 0.1 M, Sigma) was
used as a control enzyme. To assess the area of enzy-
matic digestion, 4 mice per time point were euthanized
at 2, 7 and 14 days after injection of ChABC, and brain
coronal sections were stained with the lectin Wisteria
floribunda Agglutinin (WFA) to visualize spared PNNs
(see below for detailed staining protocol).
Motor tests
For evaluation of over-ground locomotion and recovery of
motor functions the Basso Mouse Scale (BMS) score was
used (Basso et al. 2006). Mice were evaluated at day -1
and 3, 7, 14, 21 and 28 dpi. Mice were observed while
walking in an open field (60 9 43 cm) by an experimenter
blinded to the treatment groups and a score from 0 to 9 was
assigned based on the following parameters: ankle move-
ment, plantar placing, weight support, stepping, coordina-
tion, paw position, trunk stability. Prior to injury, groups
4–7 were trained for 3 days to walk on a horizontal grid.
The horizontal grid (58 cm long 9 20 cm width, 35 cm
elevation) consisted of equally spaced rungs (at 1.2 cm
intervals). Each mouse was allowed to walk on the grid for
3 min for 3 consecutive times, resting 25 min between
each trial. On the third training day (-1 day), the three
trials were video recorded to establish a baseline. Mice
were further tested and videotaped at 3, 7, 14, 21 and
28 dpi. Videos were analysed offline. When the paw was
placed such that the limb did not slip from the rung (correct
weight-supported steps), a step was noted as successful.
The percentage of footfalls was measured as the number of
errors in foot placement out of the total number of steps
during the 3-min recording or till a maximum of 50 steps
per side. The percentage for each animal was determined
by averaging over the first two trials. The right and left
paws were analysed separately.
Table 1 Experimental groups
Strain Enzymatic treatment Injury Motor test Tracing
Group 1 (n = 4) GAD67?/EGFP n.p. n.p. n.p. n.p.
Group 2 (n = 7) GAD67?/EGFP n.p. T8 n.p. Retrograde DY
Group 3 (n = 12) C57BL/6 ChABC/vehicle n.p. n.p. n.p.
Group 4 (n = 6) C57BL/6 Pase n.p. BMS/grid Anterograde BDA
Group 5 (n = 7) C57BL/6 ChABC n.p. BMS/grid Anterograde BDA
Group 6 (n = 9) C57BL/6 Pase T8 BMS/grid Anterograde BDA
Group 7 (n = 9) C57BL/6 ChABC T8 BMS/grid Anterograde BDA
n.p. not performed, ChABC chondroitinase, Pase penicillinase, T8 thoracic level 8, BMS Basso Mouse Scale score, grid horizontal grid test,
DY diamidine yellow, BDA biotinylated dextran amine
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Tissue processing
Mice were euthanized with an overdose of pentobarbital
and transcardially perfused with Ringer (Fresenius Kabi,
DE) supplemented with NaNO2 (40 mM), NaCHO3
(2 mM) and heparin (50 IE/ml, B. Braun Medical AG),
followed by ice-cold 4 % paraformaldehyde in PB 0.1 M.
The brains and spinal cords were dissected and post-fixed
overnight at 4 C in the same fixative. Brains were cryo-
protected in a solution of 30 % sucrose in PB 0.1 M.
Coronal sections (40 lm) were cut with a freezing micro-
tome and serially collected as free-floating sections in PB
0.1 M. For PV and PNN staining, a complete series of
sections (i.e. 12 sections taken at 240 lm intervals, span-
ning *2.5 mm of tissue) was permeabilized and blocked
in PB 0.1 M supplemented with 0.4 % triton-X100 (PB-TX
0.1 M) and 10 % inactivated normal horse serum for 2 h at
room temperature. Sections were incubated with primary
antibody/lectin (biotinylated Wisteria floribunda agglutinin
(WFA), which labels the GAG chains of CSPGs in the
ECM and PNNs, 1:500, B-1355 Vector Lab; mouse
monoclonal anti-calcium-binding protein parvalbumin,
1:5000, PV235 Swant) at 4 C for 3 days. After several
washes in PB 0.1 M, slices were incubated with Strepta-
vidin (Streptavidin AlexaFluor-555, 4 lg/ml, Invitrogen)
or species-matched secondary antibodies (anti-mouse Al-
exaFluor-647, 4 lg/ml, Invitrogen) for 2 h at room tem-
perature. Sections were counterstained with Dapi
(1:10,000, 5 min, D3571 Invitrogen), washed in PB 0.1 M,
and mounted onto gelatin-coated slides in Vectashield-
mounting medium (Reactolab) to preserve fluorescent
labelling. All immunostainings were performed in parallel
on the same series of sections to minimize variability
between groups.
Spinal cords were cleaned from their meninges before
being divided into four parts corresponding to segments
C1–C2, segments C3–C8, segments L1–L5, and a 4-mm
piece containing the site of injury. The tissue was
embedded in a gelatin-chicken albumin solution polymer-
ized with 2.5 % glutaraldehyde as previously described
(Herzog and Brosamle 1997). The segments C1–C2 were
cut in the coronal plane (50 lm) to quantify the number of
BDA-labelled CST fibres; horizontal sections (50 lm) of
segments C3–C8 were used to quantify the number of CST
collaterals; coronal sections (50 lm) of the lumbar spinal
cords were used to assess completeness of the CST lesion
(i.e. absence of BDA-stained CST axons) in injured mice;
finally, cross-sections (50 lm) were examined at the site of
injury to measure the size and depth of the lesion. All
sections were collected in PB 0.1 M, serially mounted onto
superfrost slides (SuperFrostPlus, Menzel-Glaser, Ger-
many) and processed using the semifree-floating technique
(Herzog and Brosamle 1997). In brief, sections were
washed in TBS-0.3 % Triton X-100 (TBS-TX, 50 mM
Tris, 0.875 % NaCl, 0.3 % Triton X-100, pH 8) before
being incubated with avidin–peroxidase in TBS-TX (ABC
elite, Vector Laboratories, Burlingame, CA, USA) for 1 h
at room temperature. After an additional washing step in
TBS-TX, a pre-incubation of 10 min in TBS-TX with
0.4 % ammonium nickel sulphate (Sigma, St. Louis, MO,
USA) was performed, followed by a second pre-incubation
of 10 min in TBS-TX with 0.4 % ammonium nickel sul-
phate and 0.015 % 3,3-diaminobenzidine (DAB; Sigma,
Buchs, Switzerland). The peroxidase reaction was started
by addition of 0.004 % H2O2 and was stopped after 30 min
by extensive washes in PB 0.1 M. Sections were air-dried
and coverslipped with Eukitt (Kindler, Freiburg, Ger-
many). Sections containing the injury site were counter-
stained with cresyl violet to facilitate lesion size
measurement. Incompletely injured or overhemisected
mice were eliminated from all the analyses.
Imaging and data analyses
Images of brain sections were acquired using a Leica
TCS SP5 confocal inverted microscope or a Leica TCS
SPE II confocal microscope (Leica Microsystems).
Coordinates of the smHL cortex were defined by out-
lining the area including layer V pyramidal cell somata
retrogradely labelled by DY injection at spinal cord level
T8 (Neurolucida, MBF Biosciences). Mapping of GAB-
Aergic markers and PNNs was performed on 12 equally
spaced (240 lm interval) sections per animal covering
the entire smHL as well as rostral and lateral regions,
i.e. caudal motor forelimb (mFL) cortex and lateral
sensory forelimb (sFL) cortex, respectively (rostrocaudal
from Bregma: ?1.32; -1.16). Three sampling areas,
extending from the pia to the white matter, were defined
on the left hemisphere on each coronal section with a
mediolateral extent of 500 lm, positioned at 250 lm
intervals, starting 750 lm lateral to the midline. Medio-
lateral coordinates for sampling area 1 (0.75; 1.2);
sampling area 2 (1.45; 1.95); sampling area 3 (2.2; 2.45).
To count the number of cells positive for GAD67-GFP,
PV and WFA, the sampling areas were subdivided in
three regions of interest (ROI) according to the cortical
layers identified by DAPI nuclear counterstaining (layers
I–III, layer IV and layers V–VI). Cell counting was
performed manually with Neurolucida software (MBF
Biosciences) at a final magnification of 409. All data are
given as number of cells per ROI at the following
coordinates: ?1.08, ?0.48, 0 (Bregma), -0.48 and
-0.72. Sampling areas 1 and 2 allowed quantifying cells
in the smHL and mFL, while sampling area 3 allowed
quantifying cells in the sFL. Quantification of the
expression level of GAD67-GFP, PV and WFA was
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performed in layer V of the smHL and mFL, where most
of the changes in the number of cells expressing these
markers were observed (see ‘‘Results’’). Stacks were
acquired in layer V at a final magnification of 409. All
acquisition parameters for the same marker were identi-
cal between groups. To insure randomized, unbiased
selection of the analysed cells, a regularly spaced grid
was superimposed on every picture and all cells lying
under the axes of the grid were analysed. The optical
density (OD) and the body area were measured by out-
lining the cell body perimeter of every single cell using
the LAS AF software (Leica microsystems, Mannheim,
Germany). To minimize possible variability coming from
the staining protocol, all values were normalized for the
average intensity obtained from the control group. Col-
laterals in C3–C8 of intact and injured spinal cords were
counted in complete series of adjacent, horizontal sec-
tions using the Neurolucida software (MBF Biosciences).
The absolute number of collaterals was divided by the
length of the analysed CST. To normalize for variation
in tracing efficiency, these numbers were further divided
by the total number of traced CST fibres counted at
cervical level C1–C2 (average of 3 counts). The resulting
index represents the number of cervical collateral per
millimetre per labelled smHL CST fibres. The size of the
SCI was estimated for all mice of groups 2, 6 and 7 by
measuring the area of spared spinal cord tissue at the
lesion epicentre.
All analyses were performed on a blinded basis. All
values in the figures and in the text are presented as
the mean ± standard error of the mean. Statistical
analyses were performed using two-way ANOVAs
with the Bonferroni post hoc test or the Student’s
t test.
Results
Mapping of the axotomized corticospinal neurons
in the sensorimotor hindlimb cortex
To accurately map the region of the mouse sensorimotor
cortex innervating the lumbar spinal cord, we retrogradely
labelled the axotomized corticospinal neurons by injecting
the tracer Diamidine Yellow (DY) at the site of injury (i.e.
T8 dorsal hemisection). Serial coronal sections of the
mouse forebrains were used to map the distribution of
labelled cells and to define the coordinates of the sensori-
motor hindlimb (smHL) cortex. The rostrocaudal
(? 0.6 mm; -1.4 mm) and mediolateral (largest extension
0.76–1.78 mm) coordinates were set with reference to
Bregma and were consistent between mice (Fig. 1a). All
axotomized pyramidal neuron somata were found in layer
5b (Fig. 1b). The regions located immediately rostral and
lateral to the smHL cortex were defined as motor forelimb
(mFL) and sensory forelimb (sFL) areas, respectively
(Ayling et al. 2009; Brown et al. 2009; Ghosh et al. 2012).
The defined coordinates were used to select the sampling
areas in which quantifications of GABAergic markers and
PNNs were done.
Fig. 1 Mapping of axotomized hindlimb-projecting corticospinal
neurons in the mouse sensorimotor hindlimb (smHL) cortex. a Axo-
tomized corticospinal neurons were retrogradely labelled by injection
of the tracer Diamidine Yellow (DY) at the site of spinal cord injury
(i.e. T8). Serial coronal sections of the forebrains were used to map
the distribution of labelled cell bodies. The resulting areas are
identified in three mice (blue, green and pink areas) and superim-
posed onto a brain template (http://wholebraincatalog.org). The
rostrocaudal (?0.6 mm; -1.4 mm) and mediolateral (largest exten-
sion: 0.76 to 1.78 mm) coordinates of the smHL are shown in ref-
erence to Bregma (red spot) and were consistent between mice. White
lines represent the serial sections used for the analyses. mFL motor
forelimb, sFL sensory forelimb. b Dapi staining (dark grey) was used
to visualize the cortical layers. DY? cell bodies of axotomized
pyramidal neurons (light grey) were located in layer 5b. R right,
L left, L4 layer 4, L5a layer 5a, L5b layer 5b
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Complex spatial changes of GABAergic markers occur
in the sensory and motor cortex after SCI
We next studied the effects of a thoracic SCI on the
spatial distribution of GAD67-GFP?, PV? and WFA-
labelled PNNs (WFA? PNNs) throughout all cortical
layers of the mFL, smHL and sFL. In addition, we
focused on layer V of the mFL and smHL cortical areas
and measured the staining intensity (optical density of
single cells) of the three markers and the cell body area
of GAD67-GFP? and PV? cells (group 1, control,
n = 4; group 2, T8 injured, n = 7). No changes could be
detected in the total number of GAD67-GFP? cells in
any of the cortical layers of the smHL cortex (Fig. 2b
and Online Resource 1), suggesting that no GABAergic
cell death had occurred in the region where axotomized
neurons were located. Interestingly however, the number
of GFP? interneurons in layers I–III and V–VI was
significantly decreased in the mFL area (?1.08 rostro-
caudal; 1.37 mediolateral; layers I–III, p = 0.027, Online
Resource 1; layers V–VI, p = 0.04, Fig. 2b) and
increased in the caudal sFL area (-0.72 rostrocaudal; 2.5
mediolateral; layers I–III, p = 0.037; layers V–VI,
p = 0.011, Online Resource 1). These changes are
unlikely to be related to death or birth of new GAD67?
cells, but rather suggest modulation of GAD67 expres-
sion after SCI. Regional changes in GAD67-GFP
expression levels were confirmed by single cell body
optical density measurement in layer V of the rostral
smHL and mFL. In this regions, the intensity level of
GAD67-GFP was significantly lower in injured compared
to control mice (?1.08 p = 0.024; ?0.48 p = 0.01; 0
p = 0.036, Fig. 2a, c). In the mFL cortex, this decrease
could largely be attributed to GABAergic PV-negative
(GAD67-GFP?/PV-) cells, i.e. calretinin and/or
somatostatin cells (Tamamaki et al. 2003), (Online
Resource 2). In the smHL cortex, GABAergic interneu-
rons that had downregulated PV following injury (see
below) but could still be identified by their PNNs
(GAD67-GFP?/WFA?/PV-) also contributed to this
decrease (Online Resource 2). Finally, measurement of
GAD67-GFP? cell body area revealed a small but sig-
nificant atrophy of this cell population exclusively in the
smHL area, where axotomized CST neurons were loca-
ted (?0.48 p = 0.027; 0 p = 0.047; -0.48 p = 0.033,
Fig. 2d). No atrophy could be observed in the mFL area
Fig. 2 Analysis of GAD67-GFP? cells in cortical layers V–VI of
control and injured mice. a Representative images showing GAD67-
GFP? cells in layer V of control (left) and injured (right) mice at
?0.48 mm from Bregma. b The total number of GAD67-GFP? cells
was significantly decreased in the mFL of injured (grey bars)
compared to control (white bars) mice. No differences were observed
in the smHL cortex of the two groups. c Optical density measurement
of single cells in layer V of the smHL and mFL cortex revealed that
the expression of GAD67-GFP was significantly lower in injured
(grey bars) compared to control (white bars) mice at the boundary
between these two areas. d Measurement of GAD67-GFP? cell body
area revealed a small but significant atrophy of this cell population
exclusively in the smHL cortex of injured (grey bars) compared to
control (white bars) mice. No atrophy could be observed in the mFL
cortex. *p \ 0.05. Student’s t test
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indicating that the lower level of GAD67-GFP expres-
sion did not influence cell body area measurements.
We next focused our analysis on PV? interneurons,
which represent the primary source of cortical lateral
inhibition on pyramidal neurons (Freund and Katona
2007). In the rodent cortex, PV? cells are present in all
layers except layer I and reach their peak density in the
middle layers (van Brederode et al. 1991). Virtually all
PV? interneurons in the cortex also express GAD67
(Tamamaki et al. 2003). A significant decrease in the
number of PV? cells was found throughout layers V–VI of
the smHL cortex (?0.48 p = 0.033; 0 p = 0.027; -0.48
p = 0.024, Fig. 3a, b). These changes were largely specific
to the deeper layers, as no significant decrease was
observed in more superficial layers of the same area or in
other areas (Online Resource 3) and suggested a down-
regulation of the protein exclusively in a subpopulation of
PV? cells. Indeed, measurements of single cell body
optical density revealed that PV expression level remained
stable in the population of detectable cells (Fig. 3a, c).
Atrophy of PV? cells was minimal and only reached sta-
tistical difference at -0.48 mm caudal to Bregma
(p = 0.03, Fig. 3d). These data identify the presence of
two subpopulations of PV cells in the deeper layers of the
smHL cortex which differently responded to the injury: one
where PV expression (and to some extent GAD67-GFP, see
above) is persistently downregulated (cell undetectable by
PV immunostaining) compared to control mice, and one
that remains largely unaffected (cells detected by PV
immunostaining).
Taken together these data indicate that SCI results in
complex topographic and layer-specific changes in the
expression of GABAergic markers in sensory and motor
cortical areas. Moreover, they reveal that atrophy of
inhibitory interneurons occurs in cortical layers where
axotomized CST neurons are located.
SCI influences integrity of cortical PNNs
at the boundary between mFL and smHL
To test for changes in CSPG GAG chain integrity, we
focused our analysis on WFA? PNNs (CSPG aggre-
gates), which surround cortical PV cells. No changes in
the total number of PNNs were observed in injured
compared to control mice in any of the cortical areas
and layers analysed (Fig. 4b and Online Resource 4).
However, optical density measurement of single nets
revealed a reduced WFA intensity staining at the
Fig. 3 Analysis of PV? cells in cortical layers V–VI of control and
injured mice. a Representative images showing PV? cells in layer V
of control (left) and injured (right) mice at ?0.48 mm from Bregma.
b The total number of PV? cells was significantly decreased
throughout the deeper layers (layers V–VI) of the smHL cortex of
injured (grey bars) compared to control (white bars) mice. No
differences were observed in the mFL cortex of the two groups.
c Optical density measurement of single cells in layers V of the smHL
and mFL cortex revealed that the expression levels of PV were
comparable in the positive cell populations of control (white bars) and
injured (grey bars) mice. d Atrophy of PV? cells was minimal in
injured mice (grey bars) and only reached statistical difference at
-0.48 mm caudal from Bregma compared to the control group (white
bars). *p \ 0.05. Student’s t test
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boundary between mFL and smHL cortical areas (?1.08
p = 0.046; ?0.48 p = 0.03, Fig. 4a, c). In this region,
PNNs appeared thinner and fainter in injured compared
to control mice (Fig. 4a). To gain insight into the
interplay between PV and integrity of PNNs, we mea-
sured the optical density of WFA? PNNs in individual
PV? (GAD67-GFP?/WFA?/PV?) and PV- (GAD67-
GFP?/WFA?/PV-) cells. This analysis revealed that a
reduction of WFA intensity occurred in both PV? and
PV- subgroups suggesting that changes in cortical
integrity of PNNs and PV expression after SCI are not
directly related (Online Resource 5).
It is interesting to note that the reduction of PNN
staining intensity occurred in a cortical region (at the
boundary between the more rostral smHL and caudal mFL
cortex) where axotomized CST neurons undergoing spon-
taneous anatomical and functional remodelling after SCI
are located (Bareyre et al. 2004; Fouad et al. 2001; Ghosh
et al. 2010). In particular, axotomized CST neurons located
in the rostral smHL cortex form cervical axonal collaterals,
which support recovery of motor functions after thoracic
SCI (Fouad et al. 2001; Ghosh et al. 2010). In light of
evidence showing restriction of structural and functional
plasticity mediated by PNNs in the mature CNS, we
hypothesized that changes in cortical PNN CSPGs integrity
after SCI might be instrumental for CST remodelling in the
spinal cord. We therefore tested if experimental widespread
digestion of cortical CSPG GAG chains would have
influenced spontaneous anatomical CST plasticity and
recovery of motor functions.
We injected ChABC or the control enzyme Pase into the
left smHL cortex of C57/Bl6 mice in combination with
(groups 6 and 7) or without a complete T8 CST transection
(groups 3–5). At 3 days post-injection, the area of enzy-
matic digestion had a rostrocaudal extension of
2.709 ± 0.125 mm starting at ?0.942 ± 0.137 mm from
Bregma, thus including the boundary between mFL and
smHL and the smHL cortex. This area was almost com-
pletely devoid of PNNs (Fig. 5a). In the digested area,
measurement of WFA-stained sections at 3, 7 and 14 days
after ChABC treatment revealed a gradual reappearance of
PNNs (Fig. 5a–c). The density of WFA? PNNs however
remained below control levels at all time points (number of
WFA? PNNs/100 lm2 at day 3 after the injection:
1.91 ± 0.26, p \ 0.001; 7: 4.86 ± 0.37, p = 0.03; 14:
4.77 ± 0.49, p = 0.03, Fig. 5b), and was significantly dif-
ferent 3 days after injection compared to both longer time
points (3 vs. 7 days, p \ 0.001; 3 vs. 14 days, p \ 0.01).
Intracortical ChABC injection transiently exacerbates
motor deficits
To address the effects of cortical CSPG GAG chains
digestion on motor function recovery, mice of groups 4–7
were assessed using the Basso Mouse Scale (BMS) score
and the horizontal grid walking test at different time points
after injury. The BMS score evaluates over-ground loco-
motor activity in an open field. The two control unlesioned
groups (groups 4 and 5) reached the highest score
throughout the testing period (Fig. 6a) indicating that
Fig. 4 Analysis of PNN
surrounded cells in cortical
layers V–VI of control and
injured mice. a Representative
images showing WFA? PNNs
in layer V of control (left) and
injured (right) mice at
?0.48 mm from Bregma. In this
region, PNNs of injured mice
appeared thinner and fainter
compared to control mice. b No
changes in the total number of
WFA? PNNs were observed in
injured (grey bars) compared to
control (white bars). c Optical
density measurement of single
nets revealed a reduced WFA
staining intensity at the
boundary between mFL and
smHL cortical areas. *p \ 0.05.
Student’s t test
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neither ChABC nor Pase intracortical injection per se
affected the gross locomotor ability of uninjured mice.
During the 4 weeks post-injury, the locomotor rating scale
of the injured groups 6 and 7 remained significantly lower
than the control groups (group 4 and 5, respectively) and
never recovered to control level. Importantly, the BMS
scores were consistent between injured mice and compa-
rable between the two groups, suggesting that locomotion
and the extent of the lesion were similar in all mice.
The horizontal grid test examines the deficits in
descending fine motor control and therefore represents a
more specific test to assess CST integrity. Video
recording allowed us to quantify the number of hindpaw
slips (footfalls, Fig. 6b) on both sides (i.e. contralateral
and ipsilateral to the injection). Digestion of CSPGs in
the sensorimotor cortex of unlesioned mice did not affect
CST-dependent descending motor control (Fig. 6c, d).
All unlesioned mice of groups 4 and 5 (Pase and
ChABC injected, respectively) walked on the grid with
ease, showing correct hindpaw placement. In contrast,
mice of both injured groups 6 and 7 showed poor per-
formance in the first 2 weeks after injury when compared
with the respective control mice (Fig. 6c, d). Interest-
ingly, stepping with the right hindpaw (opposite to the
site of cortical injection) was more severely impaired in
injured mice treated with ChABC (i.e. group 7), when
compared with injured Pase-treated mice (i.e. group 6).
The severity of this deficit reached the highest and sig-
nificant levels at 3 and 7 dpi (at 3 dpi ***p \ 0.001; at
7 dpi **p \ 0.01 two-way ANOVA with Bonferroni post
hoc test), when cortical PNNs were fully digested, and
returned to values comparable to injured Pase-treated
mice at 14 dpi, when PNNs-CSPGs reappeared in the
digested area (Figs. 5a, 6c). By 28 dpi, both injured
groups had recovered fine motor function of the right
hindpaw to control levels.
Fig. 5 Reconstruction of ChABC-digested area and gradual reap-
pearance of PNNs at 3, 7 and 14 days after ChABC injection. a The
digested area (yellow) was superimposed onto a brain template (http://
wholebraincatalog.org). The orange circle outlines the smHL area.
The area devoid of WFA staining had a rostrocaudal extension of
2.709 ± 0.125 mm and included the boundary between mFL and
smHL, and the smHL cortex. Magnifications show PNNs in the
digested area (ipsilateral to the injection) and in the contralateral
vehicle-treated hemicortex (only at 3 days post-injection). Note the
gradual reappearance of PNNs at 7 and 14 days as thin and faint
structures. b, c In the digested area, the density of WFA? PNNs was
below control levels (day 0) at all time points analysed and a gradual
increase of WFA staining intensity could be observed. *p \ 0.05,
**p \ 0.01, ***p \ 0.001. R right, L left. Student’s t test
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All together these data indicate that cortical CSPG GAG
chains digestion transiently exacerbates functional CST-
associated motor deficits after thoracic SCI.
Intracortical ChABC injection impairs the spontaneous
intraspinal sprouting of axotomized CST neurons
Sprouting of the CST has been shown to occur spontane-
ously after SCI, leading to the formation of new intraspinal
functional circuits (Bareyre et al. 2004) that participate in
the functional reorganization of the sensorimotor cortex
(Fouad et al. 2001; Ghosh et al. 2009). Thus, immediately
after completion of behavioural testing (28 dpi), the CST
originating in the left hemisphere was anterogradely traced
with BDA in groups 4–7, and the animals were euthanized
2 weeks later. The size of the SCI was estimated by mea-
suring the area of spared spinal cord tissue at the centre of
the lesion (Fig. 7a). No significant difference was detected
between groups 6 and 7 (average spared spinal cord
tissue in group 6: 0.88 ± 0.05 mm2, in group 7:
0.91 ± 0.06 mm2, p = 0.755; percentage compared to
intact spinal cord in group 6: 59.52 %, in group 7:
61.16 %). In all mice of groups 6 and 7, the CST was
completely transected as demonstrated by the absence of
BDA-positive fibres in the lumbar enlargement caudal to
the lesion (Fig. 7b). Large portions of the dorso-lateral and
ventral funiculi were spared by the lesion (Fig. 7a). Cor-
tical diffusion of BDA was comparable between all groups,
with no tracer spreading into the deep white matter or
subcortical structures. BDA? cell bodies were found solely
in the smHL cortex with no cells observed in the mFL
cortex. No significant difference was observed in the
number of BDA-labelled fibres in the four groups (cross-
section at level C1–2) indicating that neither ChABC nor
Pase injections impaired BDA uptake or induced a loss of
CST neurons. Collaterals were analysed in horizontal
sections of the cervical (C3–C8) spinal cord (Fig. 7c, d).
The number of collaterals from CST axons was signifi-
cantly increased in the injured Pase-treated mice compared
to control unlesioned mice (unlesioned Pase-treated mice,
Fig. 6 Intracortical ChABC injection transiently exacerbates motor
deficits. a Functional recovery of over-ground locomotion was
assessed with the Basso Mouse Scale (BMS) score before (-1 days)
and after injury (?3, 7, 14, 21, 28 days). The two control unlesioned
groups (groups 4, pink; group 5, light blue) reached the highest score
throughout the testing period. The locomotor rating scale of the two
injured groups (group 6, red; group 7, blue triangles) was always
significantly lower than the control groups. No differences were
detected between the scores of the injured groups at any time point.
b Representative snapshot of a video recording showing a footfall
(hindpaw slips) from the grid. The lower image is given by the
reflection in a mirror positioned below the grid. White arrows indicate
the slipping hindpaw. c Mice of both injured groups 6 (group 6, red)
and 7 (group 7, blue) showed poorer performances in the first 2 weeks
after injury compared to the respective control mice (groups 4, pink;
group 5, light blue). Stepping with the right hindpaw (opposite to the
site of cortical injection) was more severely impaired in mice treated
with ChABC (group 7, blue), when compared to injured Pase-treated
mice (group 6, red). The severity of this deficit reached the highest
and significant levels at 3 and 7 dpi, when cortical PNNs were
strongly digested (see Fig. 5a–c), and returned to values comparable
to injured Pase-treated mice at 14 dpi, when PNNs reappeared in the
digested area. d The time course of spontaneous recovery for the left
hindpaw of injured ChABC-treated mice (group 7, blue) was
comparable with the left and right hindlimbs of injured Pase-treated
mice (group 6, red). Group 7 vs. group 6: **p \ 0.01, ***p \ 0.001;
group 7 vs. group 5: #p \ 0.05, ###p \ 0.001, two-way ANOVA with
Bonferroni post hoc test
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group 4, p = 0.015; unlesioned ChABC-treated mice,
group 5, p = 0.021). Surprisingly, in group 7, which
received a SCI and ChABC cortical injection, the number
of cervical collaterals was significantly lower than in group
6 (p = 0.02) and not different from the two control unle-
sioned groups, indicating that digestion of cortical CSPG
GAG chains abolished spontaneous long-term sprouting of
axotomized CST neurons rostral to the site of injury.
Discussion
In this study, we showed that a thoracic SCI in mice is
followed by specific spatial changes in the expression of
GAD67 and PV in motor and sensory cortical areas, as well
as by reduced WFA-stained PNNs at the boundary between
the smHL and mFL cortical areas. Digestion of CSPG
GAG chains over a larger sensorimotor cortical area by
intracortical ChABC injection was used as a strategy to
promote anatomical reorganization of the CST and motor
function recovery. Our results however showed that intra-
cortical ChABC injection prevented CST sprouting rostral
to the site of SCI and worsened motor control deficits,
suggesting that these cortical changes must be discrete and
tightly controlled to be of functional benefit.
Our results highlighted that a number of spatially
restricted changes occurred in GABAergic circuits of the
sensorimotor cortex after SCI. We detected an atrophy of
layer V interneurons throughout the smHL, but not in the
adjacent mFL cortex. The smHL contains the cell bodies of
axotomized CST neurons, which undergo severe atrophy
(Nielson et al. 2010; Carter et al. 2008; Tang et al. 2004;
McBride et al. 1989; Ghosh et al. 2012) as a consequence
of loss of trophic support (Tetzlaff et al. 1994; Giehl and
Tetzlaff 1996; Kobayashi et al. 1997). The decreased
metabolic activity of the axotomized pyramidal neurons
onto which GAD67? cells project might have locally
impaired trophic support and triggered the observed atro-
phy of interneurons. Such a dependence of interneurons to
pyramidal cells integrity is supported by the observation of
Fig. 7 Intracortical ChABC injection impairs spontaneous long-term
intraspinal sprouting of axotomized CST neurons. a Representative
images showing the area of spared spinal cord tissue in control mice
(control) and at the centre of the lesion in injured Pase-treated (group
6) and injured ChABC-treated mice (group 7). No significant
difference was detected between groups. b Representative images
showing the absence of BDA-positive fibres in the lumbar enlarge-
ment caudal to the lesion in injured ChABC-treated (lower picture)
compared to control ChABC-treated (upper picture) mice.
c Representative images showing BDA? collaterals in horizontal
sections of the cervical (C3–C8) spinal cord of mice in groups 4 to 7.
White arrows indicate collaterals in Pase-treated mice (group 6).
d The number of collaterals from CST axons was significantly
increased in injured Pase-treated mice compared to control unlesioned
mice of both groups. In group 7 (injured ChABC-treated mice) the
number of cervical collaterals was significantly lower than in group 6
and not different from the two control unlesioned groups. *p \ 0.05,
Student’s t test
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a similar pattern of GABAergic neurons atrophy after
projection neuron apoptosis (Al-Abdulla and Martin 2002).
Systematic cell number quantification and intensity
measurement also revealed a decreased expression of
GAD67 and PV in the sensorimotor cortex after SCI. The
decrease of these activity-dependent GABAergic markers
(Lau and Murthy 2012; Kinney et al. 2006) strongly sup-
ports the prevailing view that cortical disinhibition under-
lies experience-driven circuits remodelling. It is likely that
these cortical changes were triggered by the transection of
ascending sensory afferences, as suggested by Ghosh et al.
(2009) and studies in the visual cortex showing that eye
removal, TTX injection or monocular deprivation leads to
similar observations (Hendry and Jones 1988; Sale et al.
2007). Interestingly, a similar decline of cortical GAD67
and PV expression has also been reported in various CNS
pathologies, such as psychiatric disorders (Reynolds et al.
2004), Alzheimer’s disease (Solodkin et al. 1996), epilepsy
(Lau et al. 2000) as well as during cortical microstimula-
tion-induced circuit remodelling (Benali et al. 2008).
Under all these conditions, the decreased expression of
those markers is believed to indicate a change of neuronal
network activity. Interestingly, our work revealed that
these changes occurred in discrete regions and/or layers of
the sensorimotor cortex after SCI. Two weeks after SCI,
downregulation of GAD67 expression was observed across
the caudal mFL and rostral smHL cortex, whereas a
reduced number of PV? cells was only detected in the
deeper layers of the axotomized smHL cortex. This com-
plex pattern of disinhibition of cortical circuits might
support the profound remodelling occurring in the mFL
and smHL cortex after SCI in rodents (Fouad et al. 2001;
Ghosh et al. 2010, 2012). Interestingly, opposite changes
(i.e. increased GAD67 expression) were observed in the
intact caudal sFL, possibly aimed at confining the reorga-
nization of cortical circuits to precise cortical sensorimotor
areas (Benali et al. 2008).
In parallel to the interneuron atrophy and changes in
activity-dependent GABAergic marker expression repor-
ted above, we observed a spatially localized reduction in
the integrity of CSPG GAG chains associated with PNNs
(revealed as significant reduction in the intensity of
WFA staining). This reduction was more pronounced at
the transition region between the mFL and smHL corti-
cal areas, a region containing pyramidal neurons that
spontaneously sprout into the cervical spinal cord after
thoracic SCI (Fouad et al. 2001; Ghosh et al. 2010).
Accumulating evidence support the existence of an
interplay between experience-dependent plasticity and
integrity of PNNs. PNNs appear at the end of the critical
period for plasticity and persist in adulthood where they
restrict functional plasticity of mature neuronal circuits
(Kwok et al. 2011). Knocking out components essential
for their assembly prolongs a juvenile state of plasticity
into adulthood (Carulli et al. 2010). Enhanced expression
of metalloproteinases (MMPs), that can degrade CSPGs
forming PNNs, promotes experience-dependent cortical
reorganization (Wang et al. 2008; Michaluk et al. 2011),
and is observed together with reduced density of PNNs
in cortical areas undergoing reorganization after stroke
(Bidmon et al. 1998; Hobohm et al. 2005). In light of
these data, our results suggested that changes in the
integrity of cortical CSPG GAG chains, particularly in
PNNs, might contribute to the promotion of motor circuit
remodelling after SCI. To test if the reduction of cortical
PNN CSPG integrity observed in the rostral smHL was
instrumental to compensatory plasticity of the CST, we
performed unilateral ChABC injection to digest their
GAG chains over a larger area of the smHL cortex.
Instead of promoting recovery, our results indicated that
broad digestion of cortical CSPG GAG chains, revealed
as the absence of WFA-stained PNNs, was detrimental to
compensatory CST plasticity after SCI. This contrast
with previous studies reporting that intraspinal or intra-
thecal delivery of ChABC after SCI promotes anatomical
and functional repair of both descending motor (Barritt
et al. 2006; Bradbury et al. 2002; Carter et al. 2008;
Garcia-Alias et al. 2008, 2009; Fouad et al. 2005) and
ascending sensory projections (Cafferty et al. 2008). A
key difference between these previous studies and our
study is the site of ChABC delivery. Thus, while
ChABC activity at or around the site of SCI promotes
repair, intracortical injection of this enzyme (our study)
results in transient aggravation of behavioural deficits.
We indeed observed rapid (i.e. at 3 and 7 dpi) and limb-
specific worsening of motor function recovery, which
eventually disappeared at longer time points (i.e. 28 dpi)
when cortical PNNs reappeared in the digestion area.
The early occurrence of these deficits suggests that
ChABC-mediated digestion of PNN CSPGs disrupted
rapid changes taking place in the sensorimotor cortex
after SCI, such as reduction of intracortical inhibition
and unmasking or reorganization of synapses which
sustain motor function recovery (Jacobs and Donoghue
1991; Levy et al. 2002; Aguilar et al. 2010). It is pos-
sible that, by perturbing these rapid changes, ChABC
treatment delays the formation and/or consolidation of
new meaningful cortical circuits following injury.
Impairment of motor function recovery after intraspinal
delivery of ChABC in an animal model of SCI was also
reported by Garcia-Alias et al. (2009). In this study,
ChABC treatment induces worsening of motor tasks that
were not actively trained after the injury. Interestingly,
ChABC has a persistence of at least 10 days after a
single injection in vivo (Lin et al. 2008), which roughly
correspond to the timing of worsening of motor recovery
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that we observed in ChABC-treated animals. Afterwards,
the replacement of newly synthesized glycans in PNNs
might parallel or initiate compensatory mechanisms in
the cortex to support spontaneous motor function
recovery at longer time points (21 and 28 dpi). The
nature of these compensatory mechanisms is likely to be
diverse, including changes not only of neuronal circuit-
ries but also of neuronal intrinsic properties. For exam-
ple, a similar transient phenotype was recently reported
for pyramidal cells excitability after downregulation of
GAD67 in PV? interneurons in juvenile mice, illustrat-
ing the exquisite capacity of cortical circuits to adapt to
pathological situations (Lazarus et al. 2013).
Intracortical ChABC injection also blocked the spon-
taneous sprouting of axotomized CST fibres in the cer-
vical spinal cord (Bareyre et al. 2004; Fouad et al. 2001;
Ghosh et al. 2009). Modulation of the physiological
properties of PNNs-surrounded PV? interneurons after
ChABC treatment (Dityatev et al. 2007) might influence
the early network remodelling induced by SCI and drive
changes in cortical network activity, thereby influencing
CST sprouting abilities (Salimi et al. 2008). However,
changes of dendritic structural and functional plasticity
mediated by diffused CSPGs cannot be ruled out
(Orlando et al. 2012; de Vivo et al. 2013). CSPGs sig-
nalling through the protein tyrosine phosphatase sigma
(Shen et al. 2009), the leukocyte common antigen-related
phosphatase (Fisher et al. 2011) and the Nogo receptor
family members NgR1 and NgR3 (Dickendesher et al.
2012) is known to affect plasticity. In addition, CSPGs
may modulate signalling of growth promoting factors
(e.g. Koprivica et al. 2005). Interestingly, despite the
absence of CST sprouting in ChABC-treated mice, these
animals eventually recovered to the level of the control
Pase-treated group. This implies that a significant degree
of functional recovery was achieved that did not involve
CST sprouting in the cervical spinal cord. This sponta-
neous recovery most probably involves the reorganiza-
tion of other parallel descending motor pathways
(Raineteau and Schwab 2001).
Taken together our findings emphasize the existence of a
fine and dynamic interplay between cortical GABAergic
circuits, integrity of PNN CSPGs, and spontaneous plasticity
of the adult-injured CST. Unlike previous observations in
sensory cortical areas (Pizzorusso et al. 2002), intracortical
ChABC delivery after SCI perturbs anatomical and func-
tional CST reorganization, suggesting that spatial changes in
cortical PNN integrity must be tightly controlled for mean-
ingful reorganization of cortical motor output.
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